India's Pharmaceutical Exports

Country Profile

Iraq

Iraq is a significant market for Indian pharmaceutical exports — $141M in FY 2025–26, with 2.5× growth over the past decade. Medicines accounts for 76% of shipments, with vaccines contributing $13.7M. The compound annual growth rate since FY2015 stands at 8.7%.

🇮🇶 $141M · 2.5× growth since FY2015 · 8.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$141M
Exports FY2025–26 DGCIS
2.5×
Growth FY2015→2026
8.7%
CAGR FY2015→2026
76%
Medicines Share
5
Product Categories Supplied
Iraq is a significant market for Indian pharmaceutical exports — $141M in FY 2025–26, with 2.5× growth over the past decade. Medicines accounts for 76% of shipments, with vaccines contributing $13.7M. The compound annual growth rate since FY2015 stands at 8.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $107M (75.5%) Medicine Ingredients $14.3M (10.1%) Vaccines $13.7M (9.7%) Surgical & Hospital Supplies $3.42M (2.4%) Traditional & Herbal $3.14M (2.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Iraq in the RBI overseas direct investment dataset (2011–2026).